Navigating and Unraveling Complex Health Challenges
At HVBS-PancyBliver, we delve into the intricate connections between latent pathogens, recent pandemics, and the evolution of cardiovascular, vascular, cerebrovascular, and neurological diseases. Our mission is to shed light on these shifting health landscapes and foster a global scientific discourse to develop effective, forward-thinking solutions.
Our Specialized Expertise and Services
HVBS-PancyBliver offers expert insights and support to understand and address critical health challenges. We are dedicated to providing cutting-edge analysis and promoting a collaborative approach to medicine, contributing to the advancement of global health outcomes.
Addressing cardiovascular and atherothrombotic events
Understanding the Rise in Hypertension
We assist in understanding the rapid and unusual rise in hypertension, even in previously healthy young individuals. Our goal is to identify underlying causes and implications related to recent pandemics and stressors. By pinpointing preventable causes, we aim to implement targeted interventions and achieve novel, curative treatments through the active collaboration of caring physicians and engaged patients.
Combating Atherothrombotic Events
We analyze severe atherothrombotic events affecting vital and visceral organs and 'noble' tissues, which significantly impact global public health and societal burdens. Our goal is to develop novel interventions and preventive strategies, paving the way for an original perspective on atherothrombosis and its associated pathologies.
Preventing Severe Clinical Outcomes
Our focus is also on reducing preventable, unexplained brain hemorrhages and their severe outcomes by managing dysregulated adrenergic milieus and identifying previously unforeseen causes. Additionally, addressing post-stress hyper-acute diabetes, along with challenges related to infection and vaccination, remains a central pillar of our clinical and research agenda.
Red Flag ECG Warning Signs
We assist in understanding the triggers and underlying causes of both sudden and heralded coronary syndromes. In particular, we aim to enhance the perception and comprehension of heralding signs and symptoms, focusing on event prevention and the management of modifiable or removable organic substrates. Furthermore, we promote alert, meticulous, and informed mindsets across academia and healthcare settings, extending these insights directly to the beneficiary population.
Navigating the Journey to Recovery
We also aim to communicate the unprecedented and rapid surge in cardiovascular, vascular, hypertensive, neurovascular & neurological diseases, exacerbated by recent pandemics. We take pride in our long-standing and ongoing focus on these conditions, regardless of patient age—be they adolescents, previously healthy young adults, or the elderly. Our work continues to verify that the human body’s resources are inherently resilient and capable of recovery, whichever its age.
Anticipating Heralding Symptoms
Over a longitudinal observation period spanning the last two decades, we have meticulously analyzed and followed how peculiar may be the dawn of major atherothrombotic events affecting vital organs and 'noble' tissues. We have gained a deeper understanding of how recent pandemics have reshaped the onset and trigger mechanisms of these conditions. We are now eager to share these breakthrough insights and place our extensive experience at the disposal of the wider medical community and the public.
The Environment as a Diagnostic Mirror
The environment acts as a mirror, reflecting the collective resources and foresight of a population; consequently, the 'background' state of a nation determines its ability to react to current environmental health challenges.
By detecting and addressing these 'communicable' and environmentally-mirrored threats, we can uncover vital, yet underutilized, health data. This information has the potential to significantly broaden our medical perspectives and redefine individual and population-based health targets. Far from being a passive reflection, the environment actively impacts health outcomes if the data it provides are not adequately harnessed and capitalized.
As such, we aim to engage stakeholders, policymakers, and state representatives with this awareness. Our goal is to address newly identified environmental health determinants at a local level, ultimately improving health outcomes at both the national and community scales.
Reaching the Central Nervous System
A new infectious determinant of health and disease, potentially more impactful than SARS-CoV-2, is emerging. It appears that the path for this agent was significantly prepared by the recent pandemic, a connection increasingly recognised.
Disseminated through the environment and transmitted via personal contact, this pathogen finds its primary reservoir within human hosts. Far from being confined to the circulating bloodstream and lymphatic systems, this infectious noxa demonstrates a high affinity for the distal beds of vital parenchymal tissues. While the brain bears a heavy burden when targeted by high pathogen titers, since highly vascularized, it also serves as a clinical litmus tissue.
Indeed, brain 3 Tesla magnetic resonance imaging (3T MRI) is uniquely suited for the early detection of even initial stages of this invasive disease. Beyond the primarily targeted bowel system, this 'per se' invasive pathogen also reaches the heart, pancreas, muscles, and liver.
Beyond Diagnostic Surgery: A New Era?
While this noxa was historically categorized as a 'neglected infectious disease', diagnosis was primarily dependent on neurosurgical intervention or the retrieval of the adult worm from the intestinal tract.
However, these pathways are no longer viable or efficient. Surgery imposes an excessive organisational burden and risk, while parasitological detection of the adult form suffers from unreliable sensitivity and specificity in cases of systemic tissue dissemination, and difficult -to-retrieve adult worms. Consequently, modern diagnostic alternatives must be advanced to replace these outdated methods.To drastically reduce the societal burden of this debilitating disease, the carrier status of affected individuals must be identified early. We propose, as a 'litmus test', brain 3 Tesla MRI, detecting distal cysticercotic formations (extremely small, distal lesions, in low or high numbers when miliariform): these findings are a highly specific diagnostic marker for a disease typically eluding standard blood assays.
Empowering People with Vital Health Knowledge
Recognizing the intrinsic link between human health and ecological habitats, we propose a dual approach—from population to habitat and back—to trace the pathway of cysticercosis, a disease that has become increasingly pervasive in our time.
On the human side, the highly sensitive diagnostic detection of the earliest and smallest cysticercus formations or of their extracellular vesicles (EV, as small as 0.1 - 0.08 µ & less, containing both genetic-instructing and protein-enzyme materials) —disseminated through the bloodstream to the distal vascular beds of any organ—has not yet been sufficiently refined. However, these lesions are more readily identifiable and documentable within the brain parenchyma. Even minute, in vivo cysticerci are now visible and reportable through advanced 3 Tesla Magnetic Resonance Imaging (3T MRI).
Conversely, on the habitat side, significant efforts are still required to establish and meet stringent safety requirements.
Clearly Structured and Validated Evidence
As previously indicated, fostering a significant impact on healthcare organization is pivotal. The full spectrum of atherothrombotic, hypertensive, hemorrhagic, and neurodegenerative outcomes—linked to the pervasive dissemination of cysticerci throughout the environment and the human body—remains to be adequately addressed. These pathogens act as silent 'pollutants' of human, animal, and planetary health.
Given the global nature of this threat, our focus includes building international networks of informed institutions and professionals dedicated to advancing diagnosis and care. While a human vaccine to reduce environmental and population burdens is not yet available—as current vaccines are limited to swine for zootechnical purposes—much remains to be done. We must promote and support environmental safety initiatives, involving all stakeholders entitled to protect our shared ecosystems.
Screening Before the Onset of Symptoms
Seeking to build professional, institutional, and public awareness, we have developed this agile online educational resource to foster a true 'culture of health.' Our goal is to mobilise public & non-profit organizations to achieve a central objective: the environmental detection of disease burden in both clean & wastewater systems even within Westernized contexts, by now mirroring efforts already established in high-endemicity countries.
Extensive direct experience has solidified our conviction that global mobility and human displacement have either significantly 'harmonized' previous national and continental differences—often to the detriment of public health—or exacerbated them in regions where prevalence was once low. Furthermore, the asexual replication of ova is capable of exponential growth, increasing by a factor of 10, in relation to the density of their basal concentrations. This fact highlights the critical importance of lowering detection thresholds and significantly improving diagnostic sensitivity."
Sorting Affected People from the Field
The implications of these new findings are manifold.
A widespread environmental deposition—and the subsequent community and individual transmission—of persistent, slow-growing parasitic ova (a growth rate influenced by the contextual effects of consecutive SARS-CoV pandemics) has led to higher cysticercosis titers and increased pathogenicity across diverse populations and regions.
Consequently, a histamine-mediated vascular hyper-reactivity throughout the body, alongside the activation of tissue-degenerative pathways, has ensued and continues to evolve.
Wise Advice
Recognizing the urgent need to break this interconnected ecological chain—which leads to very real and very severe human diseases—we have developed clear explanations and strategic approaches for dissemination. These resources are designed for use across all levels, from academic and teaching institutions to sector operators and key stakeholders. Our objective is to reach the general population, to identify and educate both carriers and affected individuals. Our immediate goal includes even contributing to the reduction of preventable, unexplained brain hemorrhages and their severe outcomes, as well as managing hyper-acute diabetes cases following stress, infection, or vaccination challenges.
Keying into Mediastinal Heart
We have clearly observed that acute viral replication triggers virus-induced inflammatory effects, as well as subsequent hypoxia and acidosis.
These conditions significantly facilitate the 'awakening' of latent vascular and parenchymal (mediastinal- or cardiac-seeded) cysticerci, activating both their specific replicative and histaminergic pathways in either heart and lungs. Consequently, mediastinal-centered severe atherothrombotic events may ensue, profoundly impacting global public health and societal burdens. This necessitates the urgent development of novel interventions and preventive strategies.
Multidisciplinary Case Review
Our vision is that multidisciplinary or monodisciplinary meetings are essential and effective, provided they involve open-minded, committed, and responsible specialists. Such experts must be willing to amend errors or near-misses, value evidence-based findings, and respect colleagues' insights—even when those ideas surpass their own. Furthermore, specialists must remain accountable, in writing, for the actions and directives that influence patient outcomes.
Timely Support for Unresolved Clinical Questions
We have been searching for health answers long before you—and we have found them.
We are proud to offer these insights to everyone in search of better health, whether for themselves, their loved ones, or out of a commitment to lifelong learning and general knowledge.
The world is changing; it is time to change with it.
What Can We Rely On?
Modern cardiology has established lifestyle and nutritional interventions as its cornerstones. Significant progress has been made in the pharmaceutical management of vascular atherosclerosis and atherothrombosis. However, a large percentage of atherothrombotic diseases remains unresolved.
We have identified a pivotal new cause of this condition, along with innovative solutions to address it.
Tracking the Long-Distance Spread of Pathogens
Cysticercosis is a systemic illness, far from being a confined or localized microbial disease restricted to single organs.
In the early stages of its medical history, the first published neurocysticercosis case series from South America appeared to suggest an exclusive brain infection.
However, it must be recognized that Taeniid ova, and their derived EV — smaller than 0.08 µ and containing genetic and enzymatic materials — which subsequently develop into micro-cysticerci, are capable of migrating—and consistently do so—across all body tissues and organs. They are transported through both the bloodstream and lymphatic channels, eventually depositing and layering within distal perfusion units and vascular beds. This results in a truly miliary, systemic dissemination of the pathogen throughout the body.
A New Paradigm in Modern Medicine
We have recognized the critical importance of adopting a very focused microbiological mindset.
Depending on their infective titers, Taeniid ova and EV establish themselves within the host, initially appearing harmless.
They achieve this proliferation advantage by producing steroid-like substances that facilitate a deceptive, seemingly innocuous integration with the host’s immune system.
Instead Taeniid ova and EV unbalance nutritive and cofactor host resources, and, upon encountering co-infectants, they benefit from the host's immunosuppression, while simultaneously enhancing the infectivity and pathogenicity of the co-infecting agents. Consequently, this synergy necessitates the radical treatment of intercurrent infections during any vaccination protocol, alongside the implementation of targeted anti-Taeniid measures.
A Validated Solution and Proof of Concept
The interplay between Taenia and co-infectants highlighted thus far, underscores the potency and versatility of hyperbaric oxygen therapy (HBOT).
This multi-targeted approach effectively addresses a wide range of challenges, including pathogen-induced inflammation, deranged lipid metabolism, conditions of hypoxia, and the atherothrombotic or thrombotic complications resulting from infections and other pathological processes.
Furthermore, hyperbaric oxygen treatment is a critical solution for the anaerobic metabolism of Taeniid ova, EV, and adult forms, and of other, possibly coexisting anaerobic infections.
The efficacy of HBOT in clearing infectious diseases. and mitigating complications is readily apparent; clinical improvements can be observed even with the use of 1.5 ATA residential hyperbaric chambers.
We assist in understanding the rapid and unusual rise in hypertension, even among children and previously healthy young individuals. We also analyze the increased rate of thromboses recorded over the last decade, aiming to identify the underlying causes and implications related to recent pandemics and stressors.
Advancing Scientific Debate and Collective Health Responsibility
The insights from HBVS-PancyBliver are primarily intended to spark a vital scientific debate among academia, research centers, hospitals, and primary care networks. We aim to reach communities and societies, encouraging both individuals and associations to embrace both collective and self-responsibility for their interconnected health states.
It is undeniable that recent pandemics have greatly modified pathogen global pathogen epidemiology. But let's see what the picture would be if we removed the last 12-year-long span of intervening multiple coronavirus pandemics. What would the global cysticercosis picture look like today ?
WHO 2014 projections indicated a global burden of neurocysticercosis (only the tip of the iceberg) as high as 50 million people with 50000 deaths. Based on the 2014 world population of approximately 7.2 billion, this translates to a prevalence of 1 in 144 people affected by neurocysticercosis.
This, however, appears to be a very conservative and underestimated figure. Indeed, if we apply to humans what is already known in swine—specifically that the brain is affected in only 10.7% of cases compared to other organs, particularly muscles—the estimated number of affected people worldwide would have been at least 500 million in 2014, even without the subsequent COVID-19 waves. This figure would represent a global prevalence as high as 1 in 14.4 inhabitants. Who among us is not in direct contact with the skin or body fluids of at least 14.4 people?
Among body fluids, those more likely to drive contagion according to Koch's postulates, include blood, urines, exudates, saliva (Plancarte A. Int J Parasitol 1994), and even breast milk. While cerebrospinal fluid (CSF) is largely sequestered, data remain uncertain regarding tears (found to be 50-75% concordant with CSF in Multiple Cclerosis, Hummert MW, Front Immunol 2019), sweat, and other secretions, in terms of diagnostic value and infectivity. But, beyond human-to-human transmission, contagion spread through the environment — via food, water, and air (contaminated by irrigation waters and aerosolized pasture pathogens)— requires investigation and eradication.
Given this reappraised 2014 baseline for cysticercosis, and considering the cumulative impact of twelve years marked by inadequate healthcare interventions and a lack of systemic countermeasures—further exacerbated by consecutive viral pandemics and only partially realized vaccine benefits—what can we conclude about the current state of global cysticercosis prevalence?
Furthermore, what specific types and what overall burden of cardiovascular, hypertensive, thrombotic, vascular, and neurological diseases have emerged as a consequence in the meantime?
Join Us in Advancing Global Health Solutions
Based on these premises, and through our unique reappraisal of current medical perspectives, we have established our primary goal: to foster a global scientific debate.
We invite researchers to collaborate and undertake joint scientific efforts by establishing formal agreements for structured partnerships between recognized researchers, research centers and stakeholders.
Our objective is to verify clinical realities and validate our strikingly effective therapeutic solutions.
We also invite patients in need of a supportive facility—guided by an expert and discerning medical and cardiological intellect of three decades, combined with specialized neurological expertise and a multidisciplinary network—to seek our advice.
Sign up for our newsletter and complete the form if you wish to submit specifically targeted inquiries or clinically-framed questions. Our expert will provide you with a detailed response."
Adapting to an Evolving Disease Landscape
HVBS-PancyBliver disseminates crucial knowledge and clinical insights pivotal for the diagnosis, recognition, and management of these conditions. We also provide valuable guidance on detecting local transmission pathways and preventing, not only inter-individual but within-the-same-bearing-organism, the spread of pathogenic noxa that underlie cardiovascular, cardiometabolic, and neurodegenerative processes, including demyelinating diseases.
In the United States, there is growing awareness of the shifting trends in cardiovascular diseases. This has led to direct community involvement, including the creation of information blogs such as those dedicated to documenting 'sudden deaths' both in the U.S. and worldwide, month after month
From Prairies to the Cities: a Focus on Human Health
Recognizing that we are people fundamentally embedded within the environments will foster more effective reciprocal interactions between habitats and the individuals who inhabit them.
By modifying exposures and mitigating risks within the intertwined human and environmental dimensions, we can effectively 'heal' the environment. This approach not only benefits individuals but also improves the natural kingdoms, as ecosystems are strengthened by the presence of healthy human and animal populations. Despite the fact that clear water, irrigation sources, and wastewater directly reflect the burden of disease within local human and animal populations, no systematic investigation has been undertaken or programmed to date. Conversely, such research would hold profound medical significance.
Not only is Cysticercosis Imported and Faraway, but it has also Seeded into Western countries
To date, public health policy documents have primarily involved comparative biomedical sciences, veterinary medicine, and engineering. Recent efforts published in late 2025 (e.g., Acta Tropica and PLOS Neglected Tropical Diseases) continue to reflect a surprising medical and environmental neglect regarding the actual prevalence of these diseases in Westernized and developed countries.
In particular, the lack of expert medical guidance—addressing not only the infectious-communicable 'arm' but also the atherothrombotic and neurodegenerative non-communicable effects—significantly limits the scope of such research. Only by fully grasping the widespread impact of cysticercosis-related pathologies and improving their detection can a serious, effective endeavor be undertaken. This is essential to reduce the environmental dissemination of the pathogenic noxa and to break the diseased ecosystem chain that increasingly fuels the rising burden of human disease.
From Zootechnics and Agriculture to the Cities: of Diseased Ecosystems reaching Humans and Large Urban Settlements
Taeniid eggs and EV easily spread to vegetables, hay, food and water chains, soil, animal feet, and insects.
Contaminated pastures and herbage—even at varying distances—as well as wind and air, can facilitate the dissemination of Taeniid ova and EV.
While rural lands, livestock, and crops were the initial targets for containment through agricultural and zootechnical upgrades, the extent to which these factors drive more or less contained disease transmission into urban centers—and their subsequent burden of human disease—is not yet fully understood.
As noted in a 2020 Presidential Address to the American Society of Parasitologists, the SARS-CoV-2 pandemic has exposed significant vulnerabilities in both global and local health systems.
These systems are now deeply interconnected, regardless of distance, due to global travel and food trade. Indeed, this pathogenic noxa possesses characteristics that facilitate its seeding into both rural and urban communities.
Engaging communities in a participatory project—aimed at standardizing diagnostics for non-communicable diseases and unifying environmental sampling methods—would provide a clearer picture of the regional disease burden.
Such a collective effort could bring the goal of pathogen eradication one step closer to reality.
In our view, the distinction between endemic and non-endemic regions is no longer acceptable; all geographical areas should be treated equally in terms of surveillance and prevention.
Even in small, contained foci, Taeniid ova and EV can survive for weeks, months, or even years, remaining resistant to cold and water.
Consequently, each human carrier can disseminate eggs and EV to a parasite-naive population, further entrenching and inbreeding the disease and accelerating its spread.
Where are We Centered ?
Our primary goal is to foster scientific debate on a global scale. We invite researchers and patients to share their experiences and engage in joint scientific efforts, alongside recognized research centers and stakeholders. Together, we aim to verify clinical realities and validate our strikingly effective therapeutic solutions.
(24.2.1846)
" Feeling a little poetic this evening."
Abraham Lincoln
(at 2018 European Workshop on
Magnetocardiography, describing his 4-decade-long journey in Magnetocardiography to Odysseus’ arduous journey home to Ithaca),
"Certainly all historical experience confirms the truth - that man would not have attained the possible unless time, and again he had reached out for the impossible."
Max Weber
(Declaration of Independence, July 4, 1776)
"We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain inalienable rights, among these are life, liberty, and the pursuit of happiness."
Thomas Jefferson